Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 203-206

  Soreq, Lilach ^a   Bergman, Hagai ^a,c   Israel, Zvi ^c   Soreq, Hermona ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b School of Pharmacy   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Alternative splicing; Exon microarrays; Leukocytes; Parkinson's disease; Risk markers

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; LEUKOCYTE; PARKINSON DISEASE; PRIORITY JOURNAL; RNA SPLICING;

ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84860215577     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000332598     Document Type: Article

References (13)

1. Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N Engl J Med 2003; 348: 1356-1364.
2. Braak H, Del Tredici K: Invited article: nervous system pathology in sporadic parkinson disease. Neurology 2008; 70: 1916.
3. Tanner CM, Goldman SM: Epidemiology of Parkinson's disease. Neurol Clin 1996; 14: 317-335.
4. Fahn S: Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 2003; 991: 1-14.
5. Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, Waldmeier P, Housman DE, Kazantsev A, Young AB, Hersch S: A smallmolecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse. Proc Natl Acad Sci USA 2007; 104: 16685-16689.
6. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB: Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456: 470-476.
7. Guo X, Chen QR, Song YK, Wei JS, Khan J: Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics 2011; 4: 35.
8. Prinos P, Garneau D, Lucier JF, Gendron D, Couture S, Boivin M, Brosseau JP, Lapointe E, Thibault P, Durand M, Tremblay K, Gervais- Bird J, Nwilati H, Klinck R, Chabot B, Perreault JP, Wellinger RJ, Elela SA: Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol 2011; 18: 673-679.
9. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR: Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci USA 2007; 104: 955-960.
10. Soreq L, Israel Z, Bergman H, Soreq H: Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients. J Neuroimmunol 2008; 201-202: 227-236.
11. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289-300.
12. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
13. Soreq L, Bergman H, Goll Y, Greenberg DS, Israel Z, Soreq H: Deep brain stimulation induces rapidly reversible transcript chang - es in Parkinson's leukocytes. J Cell Mol Med 2011, E-pub ahead of print, 2011 Sep 12. DOI: 10.1111/j.1582-4934.2011.01444.x.